Beauty Health (NASDAQ:SKIN) & Inari Medical (NASDAQ:NARI) Critical Review


Beauty Health (NASDAQ:SKINGet Rating) and Inari Medical (NASDAQ:NARIGet Rating) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Analyst Recommendations

This is a summary of recent ratings and price targets for Beauty Health and Inari Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health 0 1 9 0 2.90
Inari Medical 0 0 5 0 3.00

Beauty Health currently has a consensus price target of $26.11, indicating a potential upside of 91.29%. Inari Medical has a consensus price target of $106.80, indicating a potential upside of 55.46%. Given Beauty Health’s higher possible upside, equities research analysts plainly believe Beauty Health is more favorable than Inari Medical.

Valuation and Earnings

This table compares Beauty Health and Inari Medical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Beauty Health $260.09 million 7.85 -$375.11 million ($3.40) -4.01
Inari Medical $276.98 million 13.18 $9.84 million ($0.03) -2,290.00

Inari Medical has higher revenue and earnings than Beauty Health. Inari Medical is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

72.0% of Beauty Health shares are held by institutional investors. Comparatively, 67.9% of Inari Medical shares are held by institutional investors. 34.3% of Beauty Health shares are held by company insiders. Comparatively, 11.9% of Inari Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Beauty Health has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500.

Profitability

This table compares Beauty Health and Inari Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Beauty Health -117.84% -0.01% N/A
Inari Medical -0.25% -0.27% -0.23%

Summary

Inari Medical beats Beauty Health on 7 of the 13 factors compared between the two stocks.

Beauty Health Company Profile (Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer’s preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Inari Medical Company Profile (Get Rating)

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.



Receive News & Ratings for Beauty Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Beauty Health and related companies with MarketBeat.com’s FREE daily email newsletter.

Beauty Health (NASDAQ:SKIN) & Inari Medical (NASDAQ:NARI) Critical Review

Next Post

Define gun violence as a public health problem

Gun violence is a public health crisis.  In the U.S., gun violence affects people of all ages and races, but disproportionately impacts young adult males and racial/ethnic minorities. Of U.S. residents ages 15-24, homicide by gun is the second-leading cause of death for Hispanic males and the leading cause of […]